Find out all news, publications, posters and events
related to microbiome and EMIH (formerly known as APM) activities
News
04/09/2025
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
> READ
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
> READ
News
News
10/06/2025
The “Microbiome Times Forum” brought together key experts to shape the future of microbiome innovation in the European Union
> READ
The “Microbiome Times Forum” brought together key experts to shape the future of microbiome innovation in the European Union
> READ
News
05/06/2025
The European Microbiome Innovation for Health Association Welcomes 13 New Members, Strengthening Europe’s Leadership in Microbiome Innovation
> READ
The European Microbiome Innovation for Health Association Welcomes 13 New Members, Strengthening Europe’s Leadership in Microbiome Innovation
> READ
News
02/06/2025
MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease
> READ
MaaT Pharma Advances Toward Commercialization And Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease
> READ
News
09/05/2025
Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier
> READ
Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier
> READ
News
24/04/2025
EMIH Statement on FDA Commissioner Dr. Marty Makary’s Remarks Highlighting the Gut Microbiome’s Role in Health
> READ
EMIH Statement on FDA Commissioner Dr. Marty Makary’s Remarks Highlighting the Gut Microbiome’s Role in Health
> READ
News
21/03/2025
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
> READ
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
> READ
News
News
08/11/2024
EMIH is a partner of the 8th edition of the Microbiota and Health Day organized by Lyonbiopôle Auvergne-Rhône-Alpes.
> READ
EMIH is a partner of the 8th edition of the Microbiota and Health Day organized by Lyonbiopôle Auvergne-Rhône-Alpes.
> READ
News
25/09/2024
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group join forces with Microbiome Times on important deal-making event, taking place Brussels 2025
> READ
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group join forces with Microbiome Times on important deal-making event, taking place Brussels 2025
> READ
News
23/09/2024
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
> READ
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
> READ
News
14/05/2024
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
> READ
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
> READ
News
News
09/11/2023
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
> READ
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
> READ
News
24/08/2023
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
> READ
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
> READ
Events
News
